Director Masayuki Tsuneki Ranked Among the “World’s Top 2% Scientists” in Clinical Medicine
We are pleased to announce that our Director, Masayuki Tsuneki, has been selected among the World’s Top 2% Scientists in the field of Clinical Medicine (Oncology & Carcinogenesis), according to an international ranking jointly published by Stanford University (USA) and Elsevier (Netherlands).
The ranking is based on data from the academic database Scopus and evaluates researchers across 22 major scientific fields and 174 subfields. The evaluation incorporates multiple indicators, including total cites, h-index, number of single authored papers, and total cites to single authored papers.
This recognition reflects the high level of international acclaim for his research in Clinical Medicine (Oncology & Carcinogenesis), particularly his contributions to AI-driven pathological image analysis and oncology-related research.
We will continue to contribute to solving real-world challenges in medical practice and improving the quality of medical care by integrating deep clinical expertise with cutting-edge technology.
For more details:
https://topscinet.com/scientist_profile/Tsuneki,%20Masayuki/2008/?stype=single_year